- €138.70m
- €444.25m
- €766.75m
- 76
- 92
- 55
- 89
Annual cashflow statement for MEDICLIN AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9.68 | -9.03 | 1.49 | 9.72 | -10.7 |
| Depreciation | |||||
| Non-Cash Items | 7.39 | 7.63 | 3.12 | 2.35 | 21 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -18.7 | 42.3 | 3.71 | -48.8 | -18.2 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 69.6 | 118 | 82 | 34.6 | 78 |
| Capital Expenditures | -44.9 | -25.8 | -17 | -26 | -37.6 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 9.29 | 17.2 | 9.92 | 19.8 | 28.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -35.6 | -8.6 | -7.09 | -6.24 | -9.51 |
| Financing Cash Flow Items | -9.33 | -8.68 | -8.3 | -10.1 | -21.8 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -30.5 | -46.5 | -55.3 | -56.2 | -45.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.42 | 63.2 | 19.6 | -27.8 | 23 |